Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-12-19 Quart Barry D Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +325,000 325,000
2019-12-19 POYHONEN JOHN EVP, Chief Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +55,562 55,562
2019-12-19 MANHARD KIMBERLY Executive VP, Drug Development Grant or award · Employee Stock Option (Right to Buy) +120,000 120,000
2019-12-19 HOFFMAN ROBERT CFO & SVP, Finance Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2019-12-19 Christian Waage Director Grant or award · Stock Option (Right to Buy) +17,000 17,000
2019-12-19 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +23,000 23,000
2019-12-19 DAVIS STEPHEN Director Grant or award · Stock Option (Right to Buy) +15,500 15,500
2019-12-19 TANG KEVIN C Director Grant or award · Stock Option (right to buy) +17,000 17,000
2019-11-29 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion +24,000 $13.00 $312K 24,000
2019-11-29 MANHARD KIMBERLY Executive VP, Drug Development Sale −24,000 $26.00 $624K 0
2019-11-29 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion · Employee Stock Option (Right to Buy) −24,000 58,416
2019-10-04 TANG KEVIN C Director Purchase +285,714 $17.50 $5.0M 5,799,810
2019-10-03 Quart Barry D Chief Executive Officer Purchase +4,571 $17.50 $80K 94,652
2019-10-03 POYHONEN JOHN EVP, Chief Commercial Officer Purchase +5,143 $17.50 $90K 18,143
2019-10-01 DAVIS STEPHEN Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2019-10-01 DAVIS STEPHEN Director Grant or award · Stock Option (Right to Buy) +750 750
2019-07-15 POYHONEN JOHN EVP, Chief Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2019-05-22 POYHONEN JOHN Director Purchase +3,000 $17.55 $53K 13,000
2019-05-15 Christian Waage Director Purchase +1,400 $18.04 $25K 1,400
2019-05-01 MANHARD KIMBERLY Executive VP, Drug Development Sale −1,109 $18.86 $21K 0

Page 30 of 38 · 746 trades